"It’s been an excellent start to the five-year plan for Enterprise and you can read more in this review. But such is the strength, depth and diversity of our activities that it can only reflect a small proportion of the outstanding work of the UCL community. Every member of UCL is to be congratulated for a tremendously successful year and with the promise of much, much more to come."
Prof Stephen Caddick
Dr David Miller
Director, Translational Research and Industrial Partnerships (School of Life and Medical Sciences)
T: 020 7679 6584
David Miller joined UCL in September 2009 to take up a Drug Discovery Leader role with the remit of helping UCL in developing and implementing integrated drug discovery strategies and to provide drug discovery expertise in the development of a portfolio of therapeutic targets. Since joining, David has successfully implemented the UCL Therapeutic Innovation Fund which provides seed funding for therapeutic projects. In 2011, he became head of the Translational Research Office, which supports the translation of UCL’s basic and clinical research into therapies, techniques and medicinal products with therapeutic value. His role has recently grown to include leading on the development of industrial partnerships in the School of Life and Medical Sciences.
David originally trained as a pharmacist before completing a PhD in medicinal chemistry at Heriot-Watt and post-doctoral synthetic organic chemistry research in Cardiff and the ETH, Zuerich. David brings over 20 years’ experience of drug discovery science and management in the pharmaceutical industry, latterly as a Director of Medicinal Chemistry with GlaxoSmithKline.